Evidence map›Paper›PMID 25666088›Full record

ArticleMolecular and cellular biochemistry2015

Apigenin inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells.

Rajeshwari H Patil, R L Babu, M Naveen Kumar, K M Kiran Kumar, Shubha M Hegde, Govindarajan T Ramesh, S Chidananda Sharma

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Experimental and therapeutic medicine · 2026
    Article
  5. Article
  6. Flavonoids fromADMET & DMPK · 2024
    Review
  7. Antiviral Effects of Secondary Metabolites fromPlants (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Effects of 3'-isovaleryl-4'-senecioylkhellactone fromJournal of microbiology and biotechnology · 2022
    Article
  10. Article
  11. Article
  12. Effect ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Potential Antitumor Activity and Apoptosis Induction ofEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rajeshwari H PatilDepartment of Microbiology and Biotechnology, Bangalore University, Bangalore, 560 056, Karnataka, India.
R L Babu
M Naveen Kumar
K M Kiran Kumar
Shubha M Hegde
Govindarajan T Ramesh
S Chidananda Sharma
Bangalore University · INNorfolk State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute and chronic alveolar or bronchial inflammation is thought to be central to the pathogenesis of many respiratory disorders. Cytokines and granulocyte macrophage colony-stimulating factors (GM-CSF) play an important role in chronic inflammation. Activator protein-1 (AP-1) the superfamily of transcription factors is involved in proliferation, differentiation, apoptosis, and transformation including inflammation. Understanding the function and regulation of proinflammatory factors involved in inflammation may provide the novel therapeutic strategies in the treatment of inflammatory diseases. Our aim of the present study is to investigate the pro-inflammatory cytokines and pattern of AP-1 factors expressed during activation of lung adenocarcinoma A549 cells by Phorbol-12-myristate-13-acetate (PMA) and to understand the anti-inflammatory effect of apigenin. A549 cells were treated with and without PMA or apigenin, and the cell viability was assessed by MTT assay. Expressions of inflammatory mediators and different AP-1 factors were analyzed by semi-quantitative RT-PCR. IL-6 protein secreted was analyzed by ELISA, and expressions of IL-1β, c-Jun, and c-Fos proteins were analyzed by Western blotting. Activation of A549 cells by PMA, induced the expression of pro-inflammatory cytokine (IL-1β, IL-2, IL-6, IL-8, and TNF-α) mRNAs and secretion of IL-6 and the expression of specific AP-1 factors (c-Jun, c-Fos, and Fra-1). Treatment of cells with apigenin, significantly inhibited PMA-stimulated mRNA expression of above pro-inflammatory cytokines, AP-1 factors, cyclooxygenase-2, and secretion of IL-6 protein. Results suggested that the AP-1 factors may be involved in inflammation and apigenin has anti-inflammatory effect, which may be useful for therapeutic management of lung inflammatory diseases.

Indexed as

ApigeninApoptosisCell Cycle ProteinsCell Line, TumorCell SurvivalCyclooxygenase 2CytokinesHumansInflammation MediatorsInterleukin-1betaLipopolysaccharidesNitric OxideNitric Oxide Synthase Type IIProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junRNA, MessengerApigeninCell Cycle ProteinsCyclooxygenase 2CytokinesInflammation MediatorsInterleukin-1betaLipopolysaccharidesNitric OxideNitric Oxide Synthase Type IIProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junRNA, MessengerTetradecanoylphorbol AcetateTranscription Factor AP-1

Identifiers

PMID25666088
OpenAlexW1967603514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.